EVs from the TNBC cells MDA–MB–231 were shown to be enriched with extracellular growth factor receptor (EGFR) ligands, such as amphiregulin (AREG), which promote the invasiveness of recipient breast cancer cells, thereby being considered a biomarker for TNBC [121]. The gene discussed is EGFR; the disease is breast carcinoma.